Danny Con

23PUBLICATIONS
31CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical bacteriologyPredictive and prognostic markersFormal methods for softwareTraditional, complementary and integrative medicine not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Apr 24, 2026
Rethinking the dose: A Bayesian meta-analysis of infliximab intensification in acute severe ulcerative colitis.

|Mar 02, 2026
Monocyte Distribution Width Differentiates Bacterial Enterocolitis from Acute Severe Ulcerative Colitis in the Emergency Department.

Christopher F D Li Wai Suen, Shipraa Kaul, Ethan X Z Tan

|Oct 11, 2025
Editorial: Predicting Hepatocellular Carcinoma Development in Chronic Hepatitis B Patients With Metabolic Dysfunction-Do Existing Scores Clear the Bar?

Danny Con

|Oct 10, 2025
IBD 2024: Charting a New Course in IBD Proceedings of the Takeda Symposium 22-23 November 2024 W Hotel, Brisbane, Queensland, Australia.

Uma Mahadevan, Vipul Jairath, Jakob Begun

|Mar 25, 2024
Letter: Thioguanine, an under-utilised option in inflammatory bowel disease? Authors' reply.

Abhinav Vasudevan, Danny Con, Daniel R van Langenberg

|Mar 19, 2024
Safety and Effectiveness of Janus Kinase Inhibitors in the Management of Inflammatory Bowel Disease Following Liver Transplantation.

Danny Con, Patrick Hilley, Simone Chin

Pageof 4

Frequent Collaborators

5 joint publications

Abhinav Vasudevan

5 joint publications

Daniel R van Langenberg

3 joint publications

Peter De Cruz

2 joint publications

Michael R Braude